PROBLEM: Expression patterns and regulation of cytosolic pattern recognition receptors (PRR) NOD-1, NOD-2, RIG-1, and MDA5 have not been elucidated in the human female reproductive tract (FRT). METHOD OF STUDY: Primary epithelial cells (EC) isolated from Fallopian tube (FT), endometrium (EM), cervix (Cx), and ectocervix (Ecx) were treated with estradiol, poly(I:C), Neisseria gonorrhea (GC), and HIV-1. PRR mRNA expressions were analyzed by Real-time RT-PCR. Conditioned media were analyzed for IL-8 by ELISA. RESULTS: EC from all FRT compartments constitutively expressed NOD1, NOD2, RIG-1, and MDA5 with highest levels expressed by FT. Stimulation with poly(I:C) resulted in upregulation of NOD2, RIG-1, and MDA5 in all FRT compartments and correlated with increased secretion of IL-8, whereas estradiol treatment had no effects. Exposure to GC and HIV-1 IIIB but not BaL resulted in selective upregulation of NOD2 and MDA5. CONCLUSION: PRR are expressed throughout the FRT and differentially regulated by poly(I:C), GC and HIV-1.
PROBLEM: Expression patterns and regulation of cytosolic pattern recognition receptors (PRR) NOD-1, NOD-2, RIG-1, and MDA5 have not been elucidated in the human female reproductive tract (FRT). METHOD OF STUDY: Primary epithelial cells (EC) isolated from Fallopian tube (FT), endometrium (EM), cervix (Cx), and ectocervix (Ecx) were treated with estradiol, poly(I:C), Neisseria gonorrhea (GC), and HIV-1. PRR mRNA expressions were analyzed by Real-time RT-PCR. Conditioned media were analyzed for IL-8 by ELISA. RESULTS: EC from all FRT compartments constitutively expressed NOD1, NOD2, RIG-1, and MDA5 with highest levels expressed by FT. Stimulation with poly(I:C) resulted in upregulation of NOD2, RIG-1, and MDA5 in all FRT compartments and correlated with increased secretion of IL-8, whereas estradiol treatment had no effects. Exposure to GC and HIV-1 IIIB but not BaL resulted in selective upregulation of NOD2 and MDA5. CONCLUSION: PRR are expressed throughout the FRT and differentially regulated by poly(I:C), GC and HIV-1.
Authors: P S Cooke; D L Buchanan; P Young; T Setiawan; J Brody; K S Korach; J Taylor; D B Lubahn; G R Cunha Journal: Proc Natl Acad Sci U S A Date: 1997-06-10 Impact factor: 11.205
Authors: Susana N Asin; Michael W Fanger; Dunja Wildt-Perinic; Patricia L Ware; Charles R Wira; Alexandra L Howell Journal: J Infect Dis Date: 2004-06-11 Impact factor: 5.226
Authors: Uma Shanmugasundaram; J William Critchfield; Jane Pannell; Jean Perry; Linda C Giudice; Karen Smith-McCune; Ruth M Greenblatt; Barbara L Shacklett Journal: Am J Reprod Immunol Date: 2013-12-06 Impact factor: 3.886
Authors: Jia Mun Chan; Kathleen T Hackett; Katelynn L Woodhams; Ryan E Schaub; Joseph P Dillard Journal: Infect Immun Date: 2022-02-14 Impact factor: 3.609
Authors: Zheng Shen; John V Fahey; Jack E Bodwell; Marta Rodriguez-Garcia; Richard M Rossoll; Sarah G Crist; Mickey V Patel; Charles R Wira Journal: PLoS One Date: 2013-07-25 Impact factor: 3.240
Authors: Juliana Reis Machado; Marcos Vinícius da Silva; Camila Lourencini Cavellani; Marlene Antônia dos Reis; Maria Luiza Gonçalves dos Reis Monteiro; Vicente de Paula Antunes Teixeira; Rosana Rosa Miranda Corrêa Journal: Biomed Res Int Date: 2014-09-15 Impact factor: 3.411